HUTCHMED (China) Limited (HCM)
NASDAQ
$13.94+$0.0400 (+0.29%) on the dayAs of the close; data may be delayed.
HCM price, last 12 months
Key stats
- Previous close
- $13.90
- Open
- $14.06
- Day range
- $13.92 – $14.14
- 52-week range
- $9.77 – $16.40
- Volume
- 71.3K
- Avg volume (20 days)
- 95.8K
- Market cap
- $2.4B
Performance
1W+2.0%
1M+12.9%
3M+37.1%
6M−1.6%
YTD+4.6%
1Y−12.2%
vs S&P 500, 1Y−29.0 pts
Technicals and fundamentals
About HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
- Listed on
- NASDAQ
- Market cap
- $2.4B